Margolin SB - Search Results

1

Pirfenidone inhibits obliterative airway disease in a murine heterotopic tracheal transplant model.

McKane BW, Fernandez F, Narayanan K, Marshbank S, Margolin SB, Jendrisak M, Mohanakumar T. McKane BW, et al. Among authors: margolin sb. Transplantation. 2004 Mar 15;77(5):664-9. doi: 10.1097/01.tp.0000113162.48048.aa. Transplantation. 2004. PMID: 15021826

2

Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.

Zhou H, Latham CW, Zander DS, Margolin SB, Visner GA. Zhou H, et al. Among authors: margolin sb. J Heart Lung Transplant. 2005 Oct;24(10):1577-85. doi: 10.1016/j.healun.2004.11.002. J Heart Lung Transplant. 2005. PMID: 16210133

3

Pirfenidone inhibits early neointimal proliferation following arterial injury.

Waller JR, Toomey D, Metcalfe MS, Margolin SB, Nicholson ML. Waller JR, et al. Among authors: margolin sb. Transplant Proc. 2002 Aug;34(5):1486-8. doi: 10.1016/s0041-1345(02)02941-x. Transplant Proc. 2002. PMID: 12176451 No abstract available.

4

Effects of pirfenidone on vascular smooth muscle cell proliferation and intimal hyperplasia following arterial balloon injury.

Waller JR, Murphy GJ, Metcalfe MS, Bicknell GR, Saunders RN, Margolin SB, Nicholson ML. Waller JR, et al. Among authors: margolin sb. Transplant Proc. 2001 Nov-Dec;33(7-8):3816-8. doi: 10.1016/s0041-1345(01)02615-x. Transplant Proc. 2001. PMID: 11750625 No abstract available.

5

Pirfenidone inhibits early myointimal proliferation but has no effect on late lesion size in rats.

Waller JR, Murphy GJ, Bicknell GR, Sandford R, Margolin SB, Nicholson ML. Waller JR, et al. Among authors: margolin sb. Eur J Vasc Endovasc Surg. 2002 Mar;23(3):234-40. doi: 10.1053/ejvs.2001.1574. Eur J Vasc Endovasc Surg. 2002. PMID: 11914010 Free article.

6

Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats.

Suga H, Teraoka S, Ota K, Komemushi S, Furutani S, Yamauchi S, Margolin S. Suga H, et al. Exp Toxicol Pathol. 1995 Sep;47(4):287-91. doi: 10.1016/s0940-2993(11)80261-7. Exp Toxicol Pathol. 1995. PMID: 8855123

7

Pirfenidone suppressed the development of glomerulosclerosis in the FGS/Kist mouse.

Park HS, Bao L, Kim YJ, Cho IH, Lee CH, Hyun BH, Margolin SB, Park YH. Park HS, et al. Among authors: margolin sb. J Korean Med Sci. 2003 Aug;18(4):527-33. doi: 10.3346/jkms.2003.18.4.527. J Korean Med Sci. 2003. PMID: 12923329 Free PMC article.

8

Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice.

Kehrer JP, Margolin SB. Kehrer JP, et al. Among authors: margolin sb. Toxicol Lett. 1997 Feb 7;90(2-3):125-32. doi: 10.1016/s0378-4274(96)03845-3. Toxicol Lett. 1997. PMID: 9067480

9

Effect of pirfenidone against vanadate-induced kidney fibrosis in rats.

Al-Bayati MA, Xie Y, Mohr FC, Margolin SB, Giri SN. Al-Bayati MA, et al. Among authors: margolin sb. Biochem Pharmacol. 2002 Aug 1;64(3):517-25. doi: 10.1016/s0006-2952(02)01213-3. Biochem Pharmacol. 2002. PMID: 12147304

10

Open-label study of pirfenidone in patients with progressive forms of multiple sclerosis.

Bowen JD, Maravilla K, Margolin SB. Bowen JD, et al. Among authors: margolin sb. Mult Scler. 2003 Jun;9(3):280-3. doi: 10.1191/1352458503ms907oa. Mult Scler. 2003. PMID: 12814175 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters